# PCSK9 Inhibitor Cuts Heart Risk 31% in Patients Doctors Usually Just Watch

- slug: pcsk9-inhibitor-cuts-heart-risk-31-in-patients-doctors-usually-just-watch
- date: 2026-04-02
- category: Biotech & Life Sciences

The same conference that validated evolocumab left olezarsen with a question mark. The difference is what the drugs actually do to the body — and the answer is shaping the future of preventive cardiology.

---